Regulation of the pentose phosphate pathway in cancer

Abstract

Energy metabolism is significantly reprogrammed in many human cancers, and these alterations confer many advantages to cancer cells, including the promotion of biosynthesis, ATP generation, detoxification and support of rapid proliferation. The pentose phosphate pathway (PPP) is a major pathway for glucose catabolism. The PPP directs glucose flux to its oxidative branch and produces a reduced form of nicotinamide adenine dinucleotide phosphate (NADPH), an essential reductant in anabolic processes. It has become clear that the PPP plays a critical role in regulating cancer cell growth by supplying cells with not only ribose-5-phosphate but also NADPH for detoxification of intracellular reactive oxygen species, reductive biosynthesis and ribose biogenesis. Thus, alteration of the PPP contributes directly to cell proliferation, survival and senescence. Furthermore, recent studies have shown that the PPP is regulated oncogenically and/or metabolically by numerous factors, including tumor suppressors, oncoproteins and intracellular metabolites. Dysregulation of PPP flux dramatically impacts cancer growth and survival. Therefore, a better understanding of how the PPP is reprogrammed and the mechanism underlying the balance between glycolysis and PPP flux in cancer will be valuable in developing therapeutic strategies targeting this pathway.

Key words： pentose phosphate pathway (PPP); G6PD; NADPH; glucose metabolism; cancer; cell Proliferation

References

1 Amelio I, Markert EK, Ruflni A, Antonov AV, Sayan BS, Tucci P, Agostini M, Mineo TC, Levine AJ, Melino G(2013) p73 regulates serine biosynthesis in cancer. Oncogene

2 Anastasiou D, Poulogiannis G, Asara JM, Boxer MB, Jiang JK, Shen M, Bellinger G, Sasaki AT, Locasale JW, Auld DS (2011) Inhibition of pyruvate kinase M2 by reactive oxygen species contributes to cellular antioxidant responses. Science334: 1278-1283

3 Bader AG, Kang S, Zhao L, Vogt PK(2005) Oncogenic PI3K deregulates transcription and translation. Nat Rev Cancer5: 921-929

4 Bensaad K, Tsuruta A, Selak MA, Vidal MN, Nakano K, Bartrons R, Gottlieb E, Vousden KH(2006) TIGAR, a p53-inducible regulator of glycolysis and apoptosis. Cell126: 107-120

5 Berkers CR, Maddocks OD, Cheung EC, Mor I, Vousden KH(2013) Metabolic regulation by p53 family members. Cell Metab18: 617-633

6 Bleeker FE, Atai NA, Lamba S, Jonker A, Rijkeboer D, Bosch KS, Tigchelaar W, Troost D, Vandertop WP, Bardelli A (2010) The prognostic IDH1(R132) mutation is associated with reduced NADP+-dependent IDH activity in glioblastoma. Acta Neuropathol119: 487-494

7 Bonneau D, Longy M(2000) Mutations of the human PTEN gene. Hum Mutat16: 109-122

8 Cairns RA, Harris IS, Mak TW(2011) Regulation of cancer cell metabolism. Nat Rev Cancer11: 85-95

9 Candi E, Agostini M, Melino G, Bernassola F(2014) How the TP53 family proteins TP63 and TP73 contribute to tumorigenesis: regulators and effectors. Hum Mutat35: 702-714

10 Cantley LC(2002) The phosphoinositide 3-kinase pathway. Science296: 1655-1657

11 Cantley LC, Neel BG(1999) Newinsights into tumor suppression:PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway. Proc Natl Acad Sci USA96: 4240-4245

12 Cheung EC, Athineos D, Lee P, Ridgway RA, Lambie W, Nixon C, Strathdee D, Blyth K, Sansom OJ, Vousden KH(2013) TIGAR is required for efflcient intestinal regeneration and tumorigenesis. Dev Cell25: 463-477

13 Compagno M, Lim WK, Grunn A, Nandula SV, Brahmachary M, Shen Q, Bertoni F, Ponzoni M, Scandurra M, Califano A (2009) Mutations of multiple genes cause deregulation of NfkappaB in diffuse large B-cell lymphoma. Nature459: 717-721

14 Cosentino C, Grieco D, Costanzo V(2011) ATM activates the pentose phosphate pathway promoting anti-oxidant defence and DNA repair. EMBO J30: 546-555

15 Costa Rosa LF, Curi R, Murphy C, Newsholme P(1995) Effect of adrenaline and phorbol myristate acetate or bacterial lipopolysaccharide on stimulation of pathways of macrophage glucose, glutamine and O2 metabolism. Evidence for cyclic AMP-dependent protein kinase mediated inhibition of glucose-6-phosphate dehydrogenase and activation of NADP⁺-dependent ‘malic’ enzyme. Biochem J310(Pt 2): 709-714

16 da Silva CG, Jarzyna R, Specht A, Kaczmarek E(2006) Extracellular nucleotides and adenosine independently activate AMPactivated protein kinase in endothelial cells: involvement of P2 receptors and adenosine transporters. Circ Res98: e39-e47

17 Dang CV(2012) MYC on the path to cancer. Cell149: 22-35

18 Dang L, White DW, Gross S, Bennett BD, Bittinger MA, Driggers EM, Fantin VR, Jang HG, Jin S, Keenan MC (2010) Cancerassociated IDH1 mutations produce 2-hydroxyglutarate. Nature465: 966

19 DeBerardinis RJ, Lum JJ, Hatzivassiliou G, Thompson CB(2008) The biology of cancer: metabolic reprogramming fuels cell growth and proliferation. Cell Metab7: 11-20

20 Du W, Jiang P, Mancuso A, Stonestrom A, Brewer MD, Minn AJ, Mak TW, Wu M, Yang X(2013) TAp73 enhances the pentose phosphate pathway and supports cell proliferation. Nat Cell Biol15: 991-1000

21 Duvel K, Yecies JL, Menon S, Raman P, Lipovsky AI, Souza AL, Triantafellow E, Ma Q, Gorski R, Cleaver S (2010) Activation of a metabolic gene regulatory network downstream of mTOR complex 1. Mol Cell39: 171-183

22 Engelman JA(2009) Targeting PI3K signalling in cancer: opportunities, challenges and limitations. Nat Rev Cancer9: 550-562

23 Engelman JA, Luo J, Cantley LC(2006) The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism. Nat Rev Genet7: 606-619

24 Faubert B, Boily G, Izreig S, Griss T, Samborska B, Dong Z, Dupuy F, Chambers C, Fuerth BJ, Viollet B (2013) AMPK is a negative regulator of the Warburg effect and suppresses tumor growth in vivo. Cell Metab17: 113-124

25 Fets L, Anastasiou D(2013) p73 keeps metabolic control in the family. Nat Cell Biol15: 891-893

26 Gao P, Tchernyshyov I, Chang TC, Lee YS, Kita K, Ochi T, Zeller KI, De Marzo AM, Van Eyk JE, Mendell JT (2009) c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism. Nature458: 762-765

27 Garcia-Cao I, Song MS, Hobbs RM, Laurent G, Giorgi C, de Boer VC, Anastasiou D, Ito K, Sasaki AT, Rameh L (2012) Systemic elevation of PTEN induces a tumor-suppressive metabolic state. Cell149: 49-62

28 Hezel AF, Kimmelman AC, Stanger BZ, Bardeesy N, Depinho RA(2006) Genetics and biology of pancreatic ductal adenocarcinoma. Genes Dev20: 1218-1249

29 Hong X, Song R, Song H, Zheng T, Wang J, Liang Y, Qi S, Lu Z, Song X, Jiang H (2013) PTEN antagonises Tcl1/hnRNPK-mediated G6PD pre-mRNA splicing which contributes to hepatocarcinogenesis. Gut. 0:gutjnl-2013-305302v1-gutjnl-2013-305302

30 Hsu PP, Sabatini DM(2008) Cancer cell metabolism: Warburg and beyond. Cell134: 703-707

31 Hu W, Zhang C, Wu R, Sun Y, Levine A, Feng Z(2010) Glutaminase 2, a novel p53 target gene regulating energy metabolism and antioxidant function. Proc Natl Acad Sci USA107: 7455-7460

32 Huang W, Choi W, Chen Y, Zhang Q, Deng H, He W, Shi Y(2013) A proposed role for glutamine in cancer cell growth through acid resistance. Cell Res23: 724-727

33 Jiang P, Du W, Wang X, Mancuso A, Gao X, Wu M, Yang X(2011) p53 regulates biosynthesis through direct inactivation of glucose-6-phosphate dehydrogenase. Nat Cell Biol13: 310-316

34 Jiang P, Du W, Mancuso A, Wellen KE, Yang X(2013a) Reciprocal regulation of p53 and malic enzymes modulates metabolism and senescence. Nature493: 689-693

35 Jiang P, Du W, Yang X(2013b) A critical role of glucose-6-phosphate dehydrogenase in TAp73-mediated cell proliferation. Cell Cycle12: 3720-3726

36 Jiang P, Du W, Yang X(2013c) p53 and regulation of tumor metabolism. J Carcinog12: 21

37 Jones NP, Schulze A(2012) Targeting cancer metabolism—aiming at a tumour’s sweet-spot. Drug Discov Today17: 232-241

38 Jones RG, Plas DR, Kubek S, Buzzai M, Mu J, Xu Y, Birnbaum MJ, Thompson CB(2005) AMP-activated protein kinase induces a p53-dependent metabolic checkpoint. Mol Cell18: 283-293

39 Kletzien RF, Harris PK, Foellmi LA(1994) Glucose-6-phosphate dehydrogenase: a “housekeeping” enzyme subject to tissuespeciflc regulation by hormones, nutrients, and oxidant stress. FASEB J8: 174-181

40 Kohan AB, Talukdar I, Walsh CM, Salati LM(2009) A role for AMPK in the inhibition of glucose-6-phosphate dehydrogenase by polyunsaturated fatty acids. BiochemBiophys Res Commun388: 117-121

41 Kondoh H, Lleonart ME, Gil J, Wang J, Degan P, Peters G, Martinez D, Carnero A, Beach D(2005) Glycolytic enzymes can modulate cellular life span. Cancer Res65: 177-185

42 Koppenol WH, Bounds PL, Dang CV(2011) Otto Warburg’s contributions to current concepts of cancer metabolism. Nat Rev Cancer11: 325-337

43 Kroemer G, Pouyssegur J(2008) Tumor cell metabolism: cancer’s Achilles’ heel. Cancer Cell13: 472-482

44 Kuo W, Lin J, Tang TK(2000) Human glucose-6-phosphate dehydrogenase (G6PD) gene transforms NIH 3T3 cells and induces tumors in nude mice. Int J Cancer85: 857-864

45 Langbein S, Frederiks WM, zur Hausen A, Popa J, Lehmann J, Weiss C, Alken P, Coy JF(2008) Metastasis is promoted by a bioenergetic switch: new targets for progressive renal cell cancer. Int J Cancer122: 2422-2428

46 Leopold JA, Dam A, Maron BA, Scribner AW, Liao R, Handy DE, Stanton RC, Pitt B, Loscalzo J(2007) Aldosterone impairs vascular reactivity by decreasing glucose-6-phosphate dehydrogenase activity. Nat Med13: 189-197

47 Liang Y, Liu J, Feng Z(2013) The regulation of cellular metabolism by tumor suppressor p53. Cell Biosci3: 9

48 Longo L, Vanegas OC, Patel M, Rosti V, Li H, Waka J, Merghoub T, Pandolfl PP, Notaro R, Manova K (2002) Maternally transmitted severe glucose 6-phosphate dehydrogenase deflciency is an embryonic lethal. EMBO J21: 4229-4239

49 Lunt SY, Vander Heiden MG (2011) Aerobic glycolysis: meeting the metabolic requirements of cell proliferation. Annu Rev Cell Dev Biol27: 441-464

50 Maehama T, Dixon JE(1998) The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate. J Biol Chem273: 13375-13378

51 Manganelli G, Masullo U, Passarelli S, Filosa S(2013) Glucose-6-phosphate dehydrogenase deflciency: disadvantages and possible beneflts. Cardiovasc Hematol Disord Drug Targets13: 73-82

52 Manning BD, Cantley LC(2007) AKT/PKB signaling: navigating downstream. Cell129: 1261-1274

53 Matoba S, Kang JG, Patino WD, Wragg A, Boehm M, Gavrilova O, Hurley PJ, Bunz F, Hwang PM(2006) p53 regulates mitochondrial respiration. Science312: 1650-1653

54 Parsons DW, Jones S, Zhang X, Lin JC, Leary RJ, Angenendt P, Mankoo P, Carter H, Siu IM, Gallia GL (2008) An integrated genomic analysis of human glioblastoma multiforme. Science321: 1807-1812

55 Quade BJ, Wang TY, Sornberger K, Dal Cin P, Mutter GL, Morton CC(2004) Molecular pathogenesis of uterine smooth muscle tumors fromtranscriptional proflling. Genes Chromosom Cancer40: 97-108

56 Rosenwald A, Wright G, Chan WC, Connors JM, Campo E, Fisher RI, Gascoyne RD, Muller-Hermelink HK, Smeland EB, Giltnane JM (2002) The use of molecular proflling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. N Engl J Med346: 1937-1947

57 Ruflni A, Niklison-Chirou MV, Inoue S, Tomasini R, Harris IS, Marino A, Federici M, Dinsdale D, Knight RA, Melino G (2012) TAp73 depletion accelerates aging through metabolic dysregulation. Genes Dev26: 2009-2014

58 Sandulache VC, Ow TJ, Pickering CR, Frederick MJ, Zhou G, Fokt I, Davis-Malesevich M, Priebe W, Myers JN(2011) Glucose, not glutamine, is the dominant energy source required for proliferation and survival of head and neck squamous carcinoma cells. Cancer117: 2926-2938

59 Schulz E, Anter E, Zou MH, Keaney JF Jr (2005) Estradiol-mediated endothelial nitric oxide synthase association with heat shock protein 90 requires adenosine monophosphate-dependent protein kinase. Circulation111: 3473-3480

60 Schwartzenberg-Bar-Yoseph F, Armoni M, Karnieli E(2004) The tumor suppressor p53 down-regulates glucose transporters GLUT1 and GLUT4 gene expression. Cancer Res64: 2627-2633

61 Shaw RJ, Cantley LC(2006) Ras, PI(3)K and mTOR signalling controls tumour cell growth. Nature441: 424-430

62 Shen L, Sun X, Fu Z, Yang G, Li J, Yao L(2012) The fundamental role of the p53 pathway in tumor metabolism and its implication in tumor therapy. Clin Cancer Res18: 1561-1567

63 Simpson L, Parsons R(2001) PTEN: life as a tumor suppressor. Exp Cell Res264: 29-41

64 Stahmann N, Woods A, Carling D, Heller R(2006) Thrombin activates AMP-activated protein kinase in endothelial cells via a pathway involving Ca²⁺/calmodulin-dependent protein kinase kinase beta. Mol Cell Biol26: 5933-5945

65 Stanton RC(2012) Glucose-6-phosphate dehydrogenase, NADPH, and cell survival. IUBMB Life64: 362-369

66 Stearman RS, Dwyer-Nield L, Zerbe L, Blaine SA, Chan Z, Bunn PA Jr, Johnson GL, Hirsch FR, Merrick DT, Franklin WA (2005) Analysis of orthologous gene expression between human pulmonary adenocarcinoma and a carcinogen-induced murine model. Am J Pathol167: 1763-1775

67 Su LJ, Chang CW, Wu YC, Chen KC, Lin CJ, Liang SC, Lin CH, Whang-Peng J, Hsu SL, Chen CH (2007) Selection ofDDX5 as a novel internal control for Q-RT-PCR from microarray data using a block bootstrap re-sampling scheme. BMC Genomics8: 140

68 Sun W, Lee TS, Zhu M, Gu C, Wang Y, Zhu Y, Shyy JY(2006) Statins activate AMP-activated protein kinase in vitro and in vivo. Circulation114: 2655-2662

69 Suzuki S, Tanaka T, Poyurovsky MV, Nagano H, Mayama T, Ohkubo S, Lokshin M, Hosokawa H, Nakayama T, Suzuki Y (2010) Phosphate-activated glutaminase (GLS2), a p53-inducible regulator of glutamine metabolism and reactive oxygen species. Proc Natl Acad Sci USA107: 7461-7466

70 Tian WN, Braunstein LD, Pang J, Stuhlmeier KM, Xi QC, Tian X, Stanton RC(1998) Importance of glucose-6-phosphate dehydrogenase activity for cell growth. J Biol Chem273: 10609-10617

71 Towler MC, Hardie DG(2007) AMP-activated protein kinase in metabolic control and insulin signaling. Circ Res100: 328-341

72 Vander Heiden MG, Cantley LC, Thompson CB(2009) Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science324: 1029-1033

73 Varshney R, Dwarakanath B, Jain V(2005) Radiosensitization by 6-aminonicotinamide and 2-deoxy-_D-glucose in human cancer cells. Int J Radiat Biol81: 397-408

74 Wagle A, Jivraj S, Garlock GL, Stapleton SR(1998) Insulin regulation of glucose-6-phosphate dehydrogenase gene expression is rapamycin-sensitive and requires phosphatidylinositol 3-kinase. J Biol Chem273: 14968-14974

75 Warburg O(1956) On the origin of cancer cells. Science123: 309-314

76 Warburg O, Posener K, Negelein E(1924) Ueber den Stoffwechsel der Tumoren. Biochem Z152: 319-344

77 Ward PS, Patel J, Wise DR, Abdel-Wahab O, Bennett BD, Coller HA, Cross JR, Fantin VR, Hedvat CV, Perl AE (2010) The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutarate. Cancer Cell17: 225-234

78 Ward PS, Cross JR, Lu C, Weigert O, Abel-Wahab O, Levine RL, Weinstock DM, Sharp KA, Thompson CB(2012) Identiflcation of additional IDH mutations associated with oncometabolite R(-)-2-hydroxyglutarate production. Oncogene31: 2491-2498

79 Wise DR, DeBerardinis RJ, Mancuso A, Sayed N, Zhang XY, Pfeiffer HK, Nissim I, Daikhin E, Yudkoff M, McMahon SB (2008) Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction. Proc Natl Acad Sci USA105: 18782-18787

80 Wood T(1986) Physiological functions of the pentose phosphate pathway. Cell Biochem Funct4: 241-247

81 Xu Y, Osborne BW, Stanton RC(2005) Diabetes causes inhibition of glucose-6-phosphate dehydrogenase via activation of PKA, which contributes to oxidative stress in rat kidney cortex. Am J Physiol Renal Physiol289: F1040-F1047

82 Yan H, Parsons DW, Jin G, McLendon R, Rasheed BA, Yuan W, Kos I, Batinic-Haberle I, Jones S, Riggins GJ (2009) IDH1 and IDH2 mutations in gliomas. N Engl J Med360: 765-773

83 Ying H, Kimmelman AC, Lyssiotis CA, Hua S, Chu GC, Fletcher-Sananikone E, Locasale JW, Son J, Zhang H, Coloff JL (2012) Oncogenic Kras maintains pancreatic tumors through regulation of anabolic glucose metabolism. Cell149: 656-670

84 Yuneva M, Zamboni N, Oefner P, Sachidanandam R, Lazebnik Y(2007) Deflciency in glutamine but not glucose induces MYCdependent apoptosis in human cells. J Cell Biol178: 93-105

85 Zhang Z, Apse K, Pang J, Stanton RC(2000) High glucose inhibits glucose-6-phosphate dehydrogenase via cAMP in aortic endothelial cells. J Biol Chem275: 40042-40047

86 Zhao S, Lin Y, Xu W, Jiang W, Zha Z, Wang P, Yu W, Li Z, Gong L, Peng Y (2009) Glioma-derived mutations in IDH1 dominantly inhibit IDH1 catalytic activity and induce HIF-1alpha. Science324: 261-265

87 Zmijewski JW, Banerjee S, Bae H, Friggeri A, Lazarowski ER, Abraham E(2010) Exposure to hydrogen peroxide induces oxidation and activation of AMP-activated protein kinase. J Biol Chem285: 33154-33164

88 Zoncu R, Efeyan A, Sabatini DM(2011) mTOR: from growth signal integration to cancer, diabetes and ageing. Nat Rev Mol Cell Biol12: 21-35

89 Zou MH, Hou XY, Shi CM, Kirkpatick S, Liu F, Goldman MH, Cohen RA(2003) Activation of 5’-AMP-activated kinase is mediated through c-Src and phosphoinositide 3-kinase activity during hypoxia-reoxygenation of bovine aortic endothelial cells. Role of peroxynitrite. J Biol Chem278: 34003-34010